Hosted on MSN1d
Neurocrine Wins FDA Approval For Genetic Disorder Drug
Neurocrine Biosciences won Food and Drug Administration approval late Friday for the first new treatment for an adrenal disease in decades.
US FDA approves Neurocrine Biosciences' genetic disorder drug
The U.S. Food and Drug Administration has approved Neurocrine Biosciences' drug to treat a type of genetic disorder, the ...
Daily1d
Prenatal 2D Ultrasound reveals significant adrenal gland adaptation in patients with Fetal growth restriction: Study
Fetal growth restriction (FGR) is defined as a pathological in utero growth disorder primarily caused by factors related to ...
Sparrow Pharmaceuticals Collaborates with the University of Oxford and the University of Sheffield on DC-MACS, a Phase 2 Clinical Study of Clofutriben
Sparrow Pharmaceuticals, an emerging, clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs in both immunology and endocrinology, is collaborating with ...
Endocrinology Advisor3d
Adrenal Mass Malignancy Predictors Include Rapid Growth, Right-Sided Laterality
Adrenal mass malignancy predictors included rapid growth rate, hormonal overproduction, and right-sided laterality.
Did a fight with a loved one leave you ill? How conflict weakens the immune system
When conflict becomes a recurring pattern, it shifts from occasional stress to chronic strain on the body. The stress builds ...
Doctor says there's one thing women need 'dramatically' more of than men
A doctor has taken to social media to shed some light on something women need 'dramatically' more of than men, and it's all ...